Related Experiment Video
Updated: Mar 17, 2026

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses
Published on: April 4, 2019
[Epidemiology, Mechanisms, and Clinical Challenges of Respiratory Syncytial Virus Co-infections in Children]
Hongyuan Huang1, Huilian Chen1, Lina Qiao1
1( 610041)Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu 610041, China.
Insights
Respiratory syncytial virus (RSV) co-infections with bacteria or adenoviruses worsen illness in children. Other viral co-infections may prolong sickness but not increase severity, highlighting the need for better RSV treatments.
Area of Science:
- Pediatrics
- Virology
- Epidemiology
Background:
- Respiratory syncytial virus (RSV) is a major cause of respiratory illness in young children globally.
- No specific treatment for RSV infection is widely available.
- The impact of RSV co-infections on disease outcomes is debated despite increased detection.
Purpose of the Study:
- To investigate the epidemiological features of RSV co-infections.
- To analyze the clinical implications of RSV co-infections.
- To explore potential mechanisms behind RSV co-infections.
Main Methods:
- Epidemiological analysis of RSV co-infections.
- Clinical data review for co-infected patients.
- Literature review on molecular mechanisms.
Main Results:
- RSV co-infections with bacteria or adenoviruses are linked to severe symptoms and complex treatment.
- Co-infections with other viruses may prolong illness duration but do not necessarily increase severity.
- Mechanisms underlying RSV co-infections require further elucidation.
Conclusions:
- RSV co-infections significantly impact disease severity and treatment needs.
- Further research is crucial for understanding molecular mechanisms.
- Development of targeted therapies, vaccines, and optimized strategies is essential to reduce RSV disease burden.
Abstract:
Respiratory syncytial virus (RSV) infection remains a leading cause of respiratory illness in infants and young children worldwide, with no widely available specific treatment. Advances in diagnostic technologies have increased the detection rate of RSV co-infections, but their impact on disease outcomes remains controversial. This work examines the epidemiological characteristics, clinical implications, and potential mechanisms of RSV co-infections. Findings indicate that RSV co-infections with bacteria or adenoviruses lead to more severe clinical symptoms and more complex treatment, while co-infections with other viruses may prolong illness without increasing severity. The specific mechanisms underlying RSV co-infections are still poorly understood. In recent years, significant breakthroughs in RSV vaccine and long-acting monoclonal antibody development have provided new tools for active prevention. Future research should focus on clarifying the molecular mechanisms of co-infections, developing targeted therapeutic drugs and vaccines, and optimizing diagnostic and treatment strategies to reduce the incidence and mortality of RSV-related diseases.
More Related Videos
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
09:14An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay
Published on: January 26, 2019
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
Pneumonia II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia III: Complications and Assessment